Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tamer Macky
First Experience With BAK-free Travoprost 0.004% in Topical Glaucoma Medication
Clinical Ophthalmology
Ophthalmology
Related publications
Efficacy, Safety, and Tolerability of Travoprost 0.004% BAK-free Versus Prior Treatment With Latanoprost 0.005% in Japanese Patients
Clinical Ophthalmology
Ophthalmology
A Randomized Crossover Study Comparing Tafluprost 0.005% With Travoprost 0.004% in Patients With Normal-Tension Glaucoma
Clinical Ophthalmology
Ophthalmology
Intraocular Pressure-Lowering Efficacy of Bimatoprost 0.03% and Travoprost 0.004% in Patients With Glaucoma or Ocular Hypertension
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Effects of Corneal Thickness on the Intraocular Penetration of Travoprost 0.004%
Eye
Medicine
Arts
Sensory Systems
Ophthalmology
Humanities
Efficacy of the Travoprost/Timolol Fixed Combination Versus the Concomitant Use of Travoprost 0.004% and Timolol 0.1% Gel Formulation
Clinical Ophthalmology
Ophthalmology
Polyquad-Preserved Travoprost/Timolol, Benzalkonium Chloride (BAK)-preserved Travoprost/Timolol, and Latanoprost/Timolol in Fixed Combinations: A Rabbit Ocular Surface Study
Advances in Therapy
Medicine
Pharmacology
Sustainability of Intraocular Pressure Reduction of Travoprost Ophthalmic Solution in Subjects With Normal Tension Glaucoma
Advances in Therapy
Medicine
Pharmacology
Efficacy and Safety of Travoprost Alone or in Combination With Other Agents for Glaucoma and Ocular Hypertension: Patient Considerations
Clinical Ophthalmology
Ophthalmology
Rates of Glaucoma Medication Utilization Among Older Adults With Suspected Glaucoma, 1992 to 2002
American Journal of Ophthalmology
Ophthalmology
